Eastwood Bio-Medical Canada Inc. (TSXV:EBM)
Canada · Delayed Price · Currency is CAD 1.830
0.00 (0.00%)
Sep 24, 2026, 12:54 PM EST
TSXV:EBM Market Cap
TSXV:EBM has a market cap or net worth of CAD 126.06 million as of September 24, 2026. Its market cap has increased by 320.69% in one year.
Market Cap
126.06M
Enterprise Value
126.12M
Revenue
787.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.83
ChartMarket Cap Chart
Since September 19, 2014, TSXV:EBM's market cap has increased from 26.94M to 126.06M, an increase of 367.89%. That is a compound annual growth rate of 13.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 126.06M | 125.93% |
| Dec 31, 2025 | 55.80M | 50.00% |
| Dec 31, 2024 | 37.20M | -1.82% |
| Dec 6, 2023 | 37.89M | -45.00% |
| Dec 30, 2022 | 68.89M | -28.57% |
| Dec 30, 2021 | 96.44M | -30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 258.20M |
| Helix BioPharma | 84.02M |
| ME Therapeutics Holdings | 60.78M |
| NurExone Biologic | 59.77M |
| BriaCell Therapeutics | 52.37M |
| MedMira | 45.61M |
| Sona Nanotech | 43.59M |
| Sharp Therapeutics | 43.26M |